We have the capital to buy back stock, yes. And we still have, I think over $40 million of approval from the Board to do so. The stock got to a level that we felt was kind of ridiculous, at 12% plus dividend yield, and some of the points we made in the prepared remarks about at a $9.11 never say never. Yes, there could be some things that happen in the portfolio. I don't think anyone can tell you that surprises can happen, even this late in the game regarding CECL reserves, or some adjustments to book value. But when you look at the $1.20 per share, which is pretty relevant, and you look at the cash balance we have, and the cash balance really is, what you need to maneuver assets in the balance sheet. From a liquidity standpoint, when assets need to get pulled out of the CLO like we've done in the past. That liquid allows you to harvest the book value and get closer to book, on resolution of assets. And as I said, it's almost $4 below the $9.11. So take out our material, take out our supplement, take out our CLO offerings. Even the CLO that we collapsed, there's a lot of information about assets there, and go through it yourself. We give a lot of disclosure and I challenge you to come up with $12. And so, we kind of looked at it the same way, and said the stock is cheap, it's cheaper than what we could make in terms of investments right now. We had the capital, so we did that. We much prefer to do our business, which is make loans, but the market for loans right now are tight. It's still thawing out. We talk about that later in this conversation. But at this point, we entered the market, we bought back - 2 million shares. The window closed and we'll continue to reassess that. And yes, if the stock dips to these levels that we bought back before, yes, we think that's, we've made a statement. We think that's an attractive level.